BSX — Boston Scientific
Data coverage, completeness and provenance for Boston Scientific in the Stock Market API — Health Care · Medical Devices.
Stored price coverage
Source date: 2026-11-20T21:00:03. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-11-20 | 41.9800 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-19 | 42.9900 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-18 | 43.6400 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-17 | 43.0300 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-16 | 43.6900 | USD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/BSX/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Profile
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Employees: 59,000 · Website: https://www.bostonscientific.com · Profile fields populated: 75%
Data completeness by statement
Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/BSX/financials.
Financial statement coverage (USD)
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (USD) | 2025-12-31 | 29 | sec_edgar | ||||
| FY2024 (USD) | 2024-12-31 | 30 | sec_edgar | ||||
| FY2023 (USD) | 2023-12-31 | 30 | sec_edgar | ||||
| FY2022 (USD) | 2022-12-31 | 31 | sec_edgar | ||||
| FY2021 (USD) | 2021-12-31 | 31 | sec_edgar |
Get BSX data via the API
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Company profile
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/BSX
Financial statements
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/BSX/financials
Computed ratios
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/BSX/metrics/summary
News & announcements
Dated press releases and announcements with source links.
GET /api/v1/companies/BSX/news
Quick start
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/BSX
Query BSX programmatically
Free tier — instant API key. Built for AI agents.
Other NYSE · Health Care companies covered
Frequently Asked Questions
- What data does the API provide for BSX?
- Stored coverage for BSX: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/BSX; inspect available source metadata for provenance.
- How complete is BSX's financial data?
- The anchor reporting period (FY2025) has 88.2% of the 17 core statement fields populated. Primary source: sec_edgar.
- What reporting periods are covered for BSX?
- 5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/BSX/financials.
- Where does BSX's data come from?
- Stored price source: yfinance. Primary source for the statement snapshot: sec_edgar. Inspect available period and field source tags at /api/v1/companies/BSX/financials; missing tags do not establish provenance.